Metro Healthcare Indonesia Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 48.2K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp130 (market cap 170.67B, 834.4K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 83.4× Zyrexindo Mandiri Buana Tbk.'s market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (834.4K versus 48.2K). Which is the better fit depends on your goals.
| CARE | ZYRX | |
|---|---|---|
Market Cap | 14.23T | 170.67B |
Volume | 48.2K | 834.4K |
Lot | 482 | 8.34K |
Turnover | 20.61M | 107.41M |
Average Price | 427.65 | 128.73 |
Value | 20.61M | 107.41M |
Indicative Equilibrium Price | 428 | 124 |
Indicative Equilibrium Volume | 400 | 51 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →